Insulin resistance and β cell function as prognostic indicator in multi-organ dysfunction syndrome

Metabolic Syndrome and Related Disorders

Volumn 7, Issue 1, 2009, Pages 47-51

  Das, Sidhartha ^a   Misra, Bijay ^a   Roul, Laxmidhar ^a   Minz, Noas Tobias ^a   Pattnaik, Madhusmita ^a   Baig, Mirza Asraf Ali ^a  

^a SCB Medical College and Hospital   (India)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; BICARBONATE; GLUCOSE BLOOD LEVEL; LACTIC ACID; TRIACYLGLYCEROL;

ADULT; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; CRITICALLY ILL PATIENT; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MULTIPLE ORGAN FAILURE; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROGNOSIS; ADOLESCENT; AGED; APACHE; BIOLOGICAL MODEL; BLOOD; CRITICAL ILLNESS; DISEASE COURSE; GLUCOSE BLOOD LEVEL; INDIA; METABOLISM; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; TIME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; APACHE; BICARBONATES; BLOOD GLUCOSE; CRITICAL ILLNESS; DISEASE PROGRESSION; FEMALE; HUMANS; INDIA; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; LACTIC ACID; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; MULTIPLE ORGAN FAILURE; TIME FACTORS; TRIGLYCERIDES; YOUNG ADULT;

EID: 59349106098     PISSN: 15404196     EISSN: None     Source Type: Journal    
DOI: 10.1089/met.2008.0025     Document Type: Article

References (24)

1. Cerra FB. Multiple organ failure syndrome. In Bihari DJ, Cerra FB (eds.):. Multiple Organ Failure. Fullerton, CA: Society of Critical Care Medicine; 1989:1.
2. Kisiboard M, Rathore SS, Inzucchi SE. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction Implications for patients with and without recognized diabetes. Criculation 2005;11:3078-3086.
3. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycemia and increase risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000;355:773-778.
4. Garber AJ, Moghissi ES, Bransome ED, Clark NG, Clement S, Cobin RH, Furnary AP, Hirsch IB, Levy P, Roberts R, Van den Berghe G, Zamudiov. American College of Endocrinology position statement on in patient diabetes and metabolic control in. Endocr Pract 2004;10:77-82.
5. American Diabetes Association. Standard of Medical Care in Diabetes, Diabetes Care 2005;28:990.
6. Inzucchi SE. Management of hyperglycemia in hospital setting. N Engl J Med 2006;355:1903-1911.
7. Vincent JL. Microvascular endothelial dysfunction; a renewed appreciation of sepsis pathophysiology. Critical Care 2001;3(supp 2):S1-S2:1186-1192.
8. Michie HR. Metabolism of sepsis and multiple organ failure. World J Surg 1996;20:460-464.
9. Carr ME. Diabetes mellitus: a hypercoagulable state. J Diabetes Complic 2001;15:44-54.
10. Ortiz A, Ziyadeh FN, Neilson EG. Expression of apoptosis-regulatory genes in renal proximal tubular epithelia cells exposed to high ambient glucose and in diabetic kidneys. J Investig Med 1997;45:50-56.
11. Anderson SK, Gjedsted J, Christiansen C, Tonnessen E. The roles of insulin and hyperglycemia in sepsis pathogenesis. J Leukoc Biol 2004;75:413-421.
12. Schrier RW, Wang W. Acute renal failure and sepsis. N Engl J Med 2004;351:159-169.
13. Carpentier YA, Scruel O. Changes in the concentration and composition of plasma lipoproteins during the acute phase response. Curr Opin Clin Nutrit Met Care 2002;5:153-158.
14. Cerra FB. Hypermetabolism, organ failure, and metabolic support. Surgery 1987;1010:1.
15. Knaus WA, Wagner DP. Multiple organ system failure: epidemiology and prognosis. Crit Care Clin 1989;55:221.
16. Matthews DR, Hosker JP, Rudenski AS et al. Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;Vol.7:28:412-419.
17. Das S, Jena RK, Panda A. Management of Critically Sick Patients With Multi System Organ Failure - a non ICU study. The Antiseptic 1998;95:388-392.
18. Martin GS, Mannino DM Eaton S, Moss M. The epidemiology of sepsis in the United States 1979 through 2000. N Engl J Med 2003;348:1546-1554.
19. Robinson LE, van Soren MH. Insulin resistance and hyperglycemia in critical illness: role of insulin in glycemic control. AACN Clin Issues 2004;15:45-62.
20. Russel JA. Management of sepsis. N Engl J Med 2006;355:1699-1713.
21. Van den Berghe G, William A, Herman G. Intensive insulin therapy in medical ICU. N Engl J Med 2001;345:1359-1367.
22. Dandona P, Ajada A, Mohanty P. Insulin inhibits intranuclear nuclear factor kappa B and stimulates IKappaB in mononuclear cells in obese subjects: Evidence for an anti-inflammatory effect? J Clin Endocrinol Metab 2001;86:3257-3265.
23. Langouche L, Vanhorebeek I, Vlassetaers D. Intensive insulin therapy protects the endothelium of critically ill patients. J Clin Invest 2005;115:2227-2286.
24. Vanhorebeek I, De Vos R, Mesotten D, Wouters PJ, De Wolf-Peeters C, Van den Berghe G. Protection of hepatocytes mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients. Lancet 2005;365:53-59.